Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Vis AN, Jansen BHE, Bodar YJL, Nieuwenhuijzen JA, Hendrikse HN, Oprea-lager DE. 177Lutetium PSMA-radioligandtherapie bij prostaatkanker. ACTA ACUST UNITED AC 2020;10:60-5. [DOI: 10.1007/s13629-019-00275-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]

For:	Vis AN, Jansen BHE, Bodar YJL, Nieuwenhuijzen JA, Hendrikse HN, Oprea-lager DE. 177Lutetium PSMA-radioligandtherapie bij prostaatkanker. ACTA ACUST UNITED AC 2020;10:60-5. [DOI: 10.1007/s13629-019-00275-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]

Number	Cited by Other Article(s)
1	¹⁷⁷Lu-PSMA for advanced prostate cancer: are we ready to play big? Eur J Nucl Med Mol Imaging 2021;48:2325-2328. [PMID: 33161440 DOI: 10.1007/s00259-020-05102-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

¹⁷⁷Lu-PSMA for advanced prostate cancer: are we ready to play big? Eur J Nucl Med Mol Imaging 2021;48:2325-2328. [PMID: 33161440 DOI: 10.1007/s00259-020-05102-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]